MX2011012362A - Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma. - Google Patents

Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.

Info

Publication number
MX2011012362A
MX2011012362A MX2011012362A MX2011012362A MX2011012362A MX 2011012362 A MX2011012362 A MX 2011012362A MX 2011012362 A MX2011012362 A MX 2011012362A MX 2011012362 A MX2011012362 A MX 2011012362A MX 2011012362 A MX2011012362 A MX 2011012362A
Authority
MX
Mexico
Prior art keywords
temperature sensitive
mycoplasma hyopneumoniae
vaccine strain
sensitive vaccine
strain
Prior art date
Application number
MX2011012362A
Other languages
English (en)
Inventor
Rima Youil
Youssef Abs El-Osta
Glenn Browning
Phillip Markham
Original Assignee
Bioproperties Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009902255A external-priority patent/AU2009902255A0/en
Application filed by Bioproperties Pty Ltd filed Critical Bioproperties Pty Ltd
Publication of MX2011012362A publication Critical patent/MX2011012362A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una cepa de vacuna de Mycoplasma hyopneumoniae, la cual comprende una mutación en cuando menos uno de los genes enlistados o como fueron depositados en el National Measurements Institute (Australia), bajo el número de acceso NM04/41259, cuya cepa es sensible a la temperatura y está atenuada, a una vacuna que comprende esta cepa, y a los métodos y usos de la misma.
MX2011012362A 2009-05-19 2010-05-19 Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma. MX2011012362A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009902255A AU2009902255A0 (en) 2009-05-19 Bacterial strain, vaccine and uses thereof
PCT/AU2010/000590 WO2010132932A1 (en) 2009-05-19 2010-05-19 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof

Publications (1)

Publication Number Publication Date
MX2011012362A true MX2011012362A (es) 2012-04-19

Family

ID=43125658

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011012362A MX2011012362A (es) 2009-05-19 2010-05-19 Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.

Country Status (17)

Country Link
US (1) US8524252B2 (es)
EP (1) EP2453913B1 (es)
JP (1) JP5744852B2 (es)
KR (1) KR101734590B1 (es)
CN (1) CN102458462B (es)
AU (1) AU2010251761B2 (es)
BR (1) BRPI1010679B1 (es)
CA (1) CA2762587C (es)
CL (1) CL2011002923A1 (es)
DK (1) DK2453913T3 (es)
EA (1) EA021102B1 (es)
ES (1) ES2579935T3 (es)
MX (1) MX2011012362A (es)
NZ (1) NZ596722A (es)
PE (1) PE20120909A1 (es)
WO (1) WO2010132932A1 (es)
ZA (1) ZA201109185B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2799732A1 (en) 2010-05-19 2011-11-24 Bioproperties Pty Ltd Methods relating to an attenuated mycoplasma
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
EP2684959A1 (en) 2012-07-10 2014-01-15 Laboratorios Hipra, S.A. Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
CN104968365B (zh) 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
KR102355614B1 (ko) 2012-12-28 2022-01-27 베링거잉겔하임베트메디카게엠베하 마이코플라스마 항원을 포함하는 면역원성 조성물
EP2913947B1 (en) * 2014-02-27 2019-11-27 ADVA Optical Networking SE Passive optical network and optical line terminal
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10071149B2 (en) 2016-05-03 2018-09-11 Brigham Young University Temperature sensitive multivalent Bordetella avium vaccines
CN113278575B (zh) * 2021-07-13 2021-12-31 南华大学 一种肺炎支原体减毒突变株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
CN1100871C (zh) * 1999-06-25 2003-02-05 江苏省农业科学院畜牧兽医研究所 猪肺炎支原体克隆致弱株
US6673567B2 (en) * 2000-03-23 2004-01-06 E. I. Du Pont De Nemours And Company Method of determination of gene function
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
JP2004537543A (ja) * 2001-07-02 2004-12-16 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ・ワクチンおよび牛におけるマイコプラズマ・ボビス低減方法
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
EP1991262A4 (en) * 2006-03-03 2009-11-04 Merial Ltd MYCOPLASMA HYOPNEUMONIAE VACCINE
RU2489164C9 (ru) * 2007-11-06 2014-01-20 ВАЙЕТ ЭлЭлСи АВИРУЛЕНТНАЯ АДЪЮВАНТНАЯ ЖИВАЯ ВАКЦИНА ПРОТИВ Mycoplasma hyopneumoniae
PL2475384T3 (pl) * 2009-09-10 2017-02-28 Merial, Inc. Nowe formulacje szczepionek obejmujące adiuwanty zawierające saponiny
US9324223B2 (en) 2012-06-08 2016-04-26 3M Innovative Properties Company Electronic monitoring home unit and installation methods

Also Published As

Publication number Publication date
CN102458462B (zh) 2014-03-19
EA021102B1 (ru) 2015-04-30
KR20120016282A (ko) 2012-02-23
BRPI1010679A2 (pt) 2017-07-18
CN102458462A (zh) 2012-05-16
US8524252B2 (en) 2013-09-03
EP2453913B1 (en) 2016-06-22
KR101734590B1 (ko) 2017-05-11
CL2011002923A1 (es) 2012-08-31
JP2012527218A (ja) 2012-11-08
ZA201109185B (en) 2012-09-26
AU2010251761B2 (en) 2014-10-09
CA2762587C (en) 2017-11-28
DK2453913T3 (en) 2016-07-25
PE20120909A1 (es) 2012-08-19
US20120135040A1 (en) 2012-05-31
EA201190311A1 (ru) 2012-06-29
NZ596722A (en) 2013-08-30
AU2010251761A1 (en) 2011-12-22
WO2010132932A1 (en) 2010-11-25
ES2579935T3 (es) 2016-08-17
EP2453913A1 (en) 2012-05-23
EP2453913A4 (en) 2013-10-30
CA2762587A1 (en) 2010-11-25
JP5744852B2 (ja) 2015-07-08
BRPI1010679B1 (pt) 2020-09-24

Similar Documents

Publication Publication Date Title
MX2011012362A (es) Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.
NZ777234A (en) Compositions comprising bacterial strains
SA113340703B1 (ar) سلالة جديدة من بكتيريا Lactobacillus Crispatus
MX2011007551A (es) Cepas de saccharomyces cerevisiae con aptitudes fitosanitarias.
GB201213932D0 (en) Fibrous structures
MX2016011984A (es) Procesos para producir etanol y levadura.
MX2013005192A (es) Cepa de pasteuria novedosa y usos de la misma.
UA104050C2 (ru) Выделенная культура sphaerodes mycoparasitica для борьбы с fusarium spp
UA115331C2 (uk) Біозахист з використанням штамів lactobacillus paracasei
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
GB0811049D0 (en) Stress,strain and fatigue measuring of well piping
MX365879B (es) Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas.
FI20116007A (fi) Serotoniinitason nostaminen ja diagnostisointi
EP3978013A3 (en) A novel live attenuated shigella vaccine
WO2009058833A3 (en) Mycoplasma bovis vaccine
PH12015500091A1 (en) Non-pathogenic f18 e.coli strain and use thereof
TR201907352T4 (tr) Atenüe edi̇lmi̇ş histophilus somni i̇çeren i̇mmünoloji̇k bi̇leşi̇mler
PH12015501273A1 (en) Probiotic strains for the treatment and/or prevention of diarrhea
MY194410A (en) Compositions and Methods to Increase Plant Yield
WO2014066903A8 (en) Biocontrol of nematodes
NZ612294A (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
WO2011095374A3 (en) Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains
MX2011005281A (es) Vacuna marcadora de salmonella.
BR112015013725A2 (pt) cepa de levedura
EA201291175A1 (ru) Способы, относящиеся к аттенуированной микоплазме

Legal Events

Date Code Title Description
FG Grant or registration